Clinical Trial Update: Treatment of Steroid Resistant GVHD by Infusion MSC [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 trial evaluating infusion of mesenchymal stem cells to treat steroid-resistant graft-versus-host disease, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Mesenchymal Stem Cell Infusion

Snippet

Sponsor: N.M. Wulffraat | Conditions: Graft-versus-host-disease | Phase 1, Phase 2 | Status: COMPLETED